All Updates

All Updates

icon
Filter
Partnerships
Illumina partners with AstraZeneca to advance drug discovery
Precision Medicine
Oct 11, 2022
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Oct 11, 2022

Illumina partners with AstraZeneca to advance drug discovery

Partnerships

  • Genomics sequencing company Illumina partnered with big pharma AstraZeneca for a research collaboration to advance drug discovery using artificial intelligence (AI)-based genomic analysis. 

  • The partnership will allow AstraZeneca to leverage Illumina’s AI-based tools PrimateAI and SpliceAI, along with AstraZeneca’s AI program Jarvis, to examine and interpret genomic data. Specifically, AstraZeneca's Centre for Genomics Research will use the combined tools to analyze data from its digital biobanks to more accurately identify genetic variants that could be linked to diseases, which would help develop more effective and safer treatments.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.